Moderna (MRNA) Revenue Growth (3y) (2020 - 2026)
Moderna (MRNA) Revenue Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,899.61 Bn | 65,899.33 Bn | - | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | - |
| 4 | BeOne Medicines | 472.68 Bn | 467.89 Bn | 1.35 Bn | 50.07% |
| 5 | Vertex Pharmaceuticals | 122.24 Bn | 114.99 Bn | 2.59 Bn | 7.94% |
| 6 | Regeneron Pharmaceuticals | 70.08 Bn | 61.33 Bn | 3.31 Bn | 4.47% |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - | - |
| 8 | Argenx Se | 55.93 Bn | 50.75 Bn | 1.41 Bn | 79.44% |
| 9 | Alnylam Pharmaceuticals | 37.59 Bn | 34.58 Bn | 959.66 Mn | 54.05% |
| 10 | Moderna | 22.24 Bn | 17.03 Bn | -566.00 Mn | -40.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40.66% |
| Dec 31, 2025 | -48.91% |
| Sep 30, 2025 | -32.91% |
| Jun 30, 2025 | -68.96% |
| Mar 31, 2025 | -73.89% |
| Dec 31, 2024 | -48.83% |
| Sep 30, 2024 | -27.91% |
| Jun 30, 2024 | -61.89% |
| Mar 31, 2024 | -55.82% |
| Dec 31, 2023 | 70.11% |
| Sep 30, 2023 | 126.78% |
| Jun 30, 2023 | 72.52% |
| Mar 31, 2023 | 515.12% |
| Dec 31, 2022 | 612.51% |
| Sep 30, 2022 | 482.21% |
| Jun 30, 2022 | 613.34% |
| Mar 31, 2022 | 623.38% |
| Dec 31, 2021 | 488.27% |
| Sep 30, 2021 | 391.87% |
| Jun 30, 2021 | 432.41% |